Local government intervention slows pharm-emerging economies

05/2/2011 | PharmExec.com

In Turkey and other emerging pharmaceutical markets, governments are taking steps to bolster domestic production, such as by subjecting foreign-made drugs to separate certification inspections that slow the flow of imports, Pharmaceutical Executive magazine editor-in-chief William Looney writes. The average time for a new drug to get marketing approval in Turkey is 772 days, compared with about 200 days in the European Union, according to a trade association.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC